Life Science Company News

Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »

KSQ Therapeutics Announces FDA Clearance of IND Application for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy

Read more ››
By: GlobeNewswire - 29 Nov 2023

LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023

Read more ››
By: GlobeNewswire - 29 Nov 2023

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease

Read more ››
By: GlobeNewswire - 29 Nov 2023

22nd Century Appoints Larry Firestone as Chairman and CEO

Read more ››
By: GlobeNewswire - 29 Nov 2023

Eagle Pharmaceuticals Announces Management Change

Read more ››
By: GlobeNewswire - 29 Nov 2023

Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Read more ››
By: GlobeNewswire - 29 Nov 2023

Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

Read more ››
By: GlobeNewswire - 29 Nov 2023

Jushi Holdings Inc. Announces Filing of Preliminary Base Shelf Prospectus

Read more ››
By: GlobeNewswire - 29 Nov 2023

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Read more ››
By: GlobeNewswire - 29 Nov 2023

Plus Therapeutics to Present at the 5th Targeted Radiopharmaceuticals Summit Europe

Read more ››
By: GlobeNewswire - 29 Nov 2023

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium

Read more ››
By: GlobeNewswire - 29 Nov 2023

BrightInsight Ranked 307th Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500

Read more ››
By: GlobeNewswire - 29 Nov 2023

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium

Read more ››
By: GlobeNewswire - 29 Nov 2023

FDA Accepts Arcutis’ Supplemental New Drug Application for Roflumilast Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to Age 6

Read more ››
By: GlobeNewswire - 29 Nov 2023

Vittoria Biotherapeutics Announces the Presentation of New Data Supporting the Company's Platform at the 65th American Society of Hematology Annual Meeting

Read more ››
By: GlobeNewswire - 29 Nov 2023

Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

Read more ››
By: GlobeNewswire - 29 Nov 2023

Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients

Read more ››
By: GlobeNewswire - 29 Nov 2023

BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s Disease

Read more ››
By: GlobeNewswire - 29 Nov 2023

Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast

Read more ››
By: GlobeNewswire - 29 Nov 2023

Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification

Read more ››
By: GlobeNewswire - 29 Nov 2023
Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate